🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

20 recruiting trials

for Advanced Osteosarcoma

A Phase 2 Trial of Zanzalintinib in Advanced/Metastatic Bone Sarcomas (ZAMBONE) NCT07193550Phase 21 site📍 Houston M.D. Anderson Cancer Center · Tests: Zanzalintinib Study of CRX100 as Monotherapy and in Combination With Pembrolizumab in Patients With Advanced Solid Malignancies NCT04282044Phase 13 sites📍 Scottsdale📍 La Jolla📍 Stanford BioEclipse Therapeutics · Tests: CRX100 suspension for infusion, Fludarabine, Cyclophosphamide Genetically Engineered Cells (FH-FOLR1 ST CAR T Cells) for the Treatment of Advanced Refractory or Recurrent/Progressive Osteosarcoma, FIERCe Trial NCT07227571Phase 11 site📍 Seattle Fred Hutchinson Cancer Center · Tests: FH FOLR1 ST CAR T-cells, Leukapheresis, Fludarabine, Cyclophosphamide, Echocardiography Test A Phase 2 Pilot Study to Evaluate the Safety and the Anti-Tumour Activity of the Myc Inhibitor OMO-103 Administered Intravenously in Patients With Advanced High-Grade Osteosarcoma NCT06650514Phase 21 site📍 Barcelona Vall d'Hebron Institute of Oncology · Tests: OMO-103 Phase II Clinical Trial of Chidamide Combined With AK112 for Second-line and Advanced Bone and Soft Tissue Sarcoma NCT06637007Phase 21 site📍 Taiyuan Shanxi Province Cancer Hospital · Tests: Chidamide Tablets combined with AK112 PARP Inhibition, Stereotactic Body Radiotherapy and Immunotherapy for Metastatic or Advanced Sarcoma (PRIMA) NCT06074692Phase 21 site📍 Shanghai Ruijin Hospital · Tests: Camrelizumab and fluzoparib with concurrent stereotactic body radiotherapy (SBRT) Sequential Infusion of CD146-Targeted and HER2-Targeted CAR T Cells in Patients With Advanced Sarcomas NCT07066982Phase 1, Phase 21 site📍 Beijing Essen Biotech · Tests: CD146/HER2 CAR-T cells T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy (attIL12-TIL) for Advanced/Metastatic Soft Tissue and Bone Sarcoma Patients. NCT06474676Phase 11 site📍 Houston M.D. Anderson Cancer Center · Tests: Cyclophosphamide, T Cell Membrane-Anchored Tumor-Targeted IL12 -Modified TIL Cell Therapy KXV01 Injection in Patients With Advanced Solid Tumor (Including Osteosarcoma and Sarcoma) NCT07596693Phase 11 site📍 Shanghai TCRx Therapeutics Co.Ltd · Tests: KXV01 TCR Lentinvivo Injection Combination of Pembrolizumab and Cabozantinib in Patients With Advanced Sarcomas NCT05182164Phase 210 sites📍 Bordeaux📍 Dijon📍 Lille Institut Bergonié · Tests: Association of pembrolizumab + cabozantinib Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration NCT04040205Phase 24 sites📍 Jacksonville📍 Iowa City📍 St Louis Medical College of Wisconsin · Tests: Abemaciclib A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma NCT06564272Phase 21 site📍 Beijing Beijing Konruns Pharmaceutical Co., Ltd. · Tests: KC1036 Cryoablation Plus Camrelizumab for Advanced Soft Tissue Sarcoma NCT07602049Phase 21 site📍 Guangzhou Sun Yat-sen University · Tests: Cryoablation therapy + anti-PD-1 antibody A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies NCT07197554Phase 16 sites📍 Duarte📍 Newport Beach📍 Boston SEED Therapeutics, Inc. · Tests: ST-01156 XL092 (Zanzalintinib) for the Treatment of Patients With Metastatic or Unresectable Leiomyosarcoma, Bone Sarcoma or Translocation-associated Soft Tissue Sarcoma NCT06571734Phase 21 site📍 Chicago Northwestern University · Tests: Biospecimen Collection, Computed Tomography, Echocardiography, Multigated Acquisition Scan, Zanzalintinib HER2 Chimeric Antigen Receptor (CAR) T Cells in Combination With Checkpoint Blockade in Patients With Advanced Sarcoma NCT04995003Phase 11 site📍 Houston Baylor College of Medicine · Tests: T cells or CAR T cells, Pembrolizumab Injectable Product, Nivolumab Injectable Product Atezolizumab and Cabozantinib for the Treatment of Adolescents and Young Adults With Recurrent or Metastatic Osteosarcoma, TACOS Study NCT05019703Phase 22 sites📍 Boston📍 Houston M.D. Anderson Cancer Center · Tests: Atezolizumab, Cabozantinib Phase 1 Study of INBRX-109 in Subjects With Locally Advanced or Metastatic Solid Tumors Including Sarcomas NCT03715933Phase 137 sites📍 Scottsdale📍 Beverly Hills📍 Duarte Inhibrx Biosciences, Inc · Tests: INBRX-109, Irinotecan, Temozolomide, carboplatin, pemetrexed Tumor Neoantigen Vaccine SarVac Combined With Tumor Specific Lymphocyte Reinfusion in the Treatment of Advanced Sarcoma NCT07648069Phase 11 site📍 Guangzhou Sun Yat-sen University · Tests: Neoantigen vaccine + specific lymphocytes + anti-PD1 antibody, Neoantigen vaccine + anti-PD1 antibody A Phase I Study of XS-02 Capsules in Patients With Advanced Solid Tumors NCT06531486Phase 11 site📍 Beijing Shanghai Fosun Pharmaceutical Industrial Development Co. Lt… · Tests: XS-02 capsules
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy